NCT06236698View on ClinicalTrials.gov

The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism

CompletedOBSERVATIONAL
Enrollment

999

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 30, 2024

Study Completion Date

October 30, 2024

Conditions
Primary AldosteronismHypertension
Interventions
DIAGNOSTIC_TEST

24-hour urinary aldosterone measurement

Collect 24-hour urine sample from each participant and complete the detection of urinary aldosterone content.

Trial Locations (1)

400042

China Chongqing The third hospital affiliated to the Third Millitary Medical University, Chongqing

All Listed Sponsors
lead

Zhiming Zhu

OTHER